Post-Stroke Medication Relay
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 54
- 试验地点
- 1
- 主要终点
- Assess the value of a telephone interview / teleconsultation after discharge from hospital following an ischemic stroke
研究概览
简要总结
Prior to discharge from hospital and return home, patients managed for ischemic stroke will receive a pharmaceutical interview to discuss their discharge prescription (indication, method of administration, precautions, and possible side effects).
Improvements in the use of medications in the community and in hospital follow-up.
Telephone interviews or teleconsultations will make it possible to assess the patient's knowledge of his or her treatment and to re-explain it if necessary to improve patient compliance with treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients managed in stroke unit following ischemic stroke
- •Benefiting from a direct return home
- •Non-opposition to participation
排除标准
- 未提供
结局指标
主要结局
Assess the value of a telephone interview / teleconsultation after discharge from hospital following an ischemic stroke
时间窗: 2 months
The value of a telephone interview / teleconsultation will be assess by comparison of treatment knowledge between the first questionnaire at one week and the second questionnaire at two months after the pharmaceutical interview and hospital discharge. Statistical evaluation by comparative tests at one week versus two months. Assessment will focus on treatment knowledge (score between 0 and 3), adherence (score between 0 and 6) and adverse events (score between 0 and 3)
Assess the value of a telephone interview / teleconsultation after discharge from hospital following an ischemic stroke
时间窗: 1 week
The value of a telephone interview / teleconsultation will be assess by comparison of treatment knowledge between the first questionnaire at one week and the second questionnaire at two months after the pharmaceutical interview and hospital discharge. Statistical evaluation by comparative tests at one week versus two months. Assessment will focus on treatment knowledge (score between 0 and 3), adherence (score between 0 and 6) and adverse events (score between 0 and 3)
次要结局
未报告次要终点